Bicara Therapeutics Inc. Common Stock

BCAX | NASDAQ

$22.01

-$0.63 (-2.78%)

At close: Sep 21, 2026, 4:00 PM ET

$22.01

$0 (0.00%)

After-hours: Sep 21, 2026, 7:30 PM ET

Fiscal Year Period Ending	FY 2025 Dec 30, 2025	FY 2024 Dec 30, 2024	FY 2023 Dec 30, 2023	FY 2022 Dec 30, 2022
Revenue	n/a	n/a	n/a	n/a
Cost of Revenue	n/a	n/a	n/a	n/a
Gross Profit	n/a	n/a	n/a	n/a
Operating Income	-155.6M	-82.39M	-39.89M	-37.66M
Interest Income	17.87M	14.58M	1.31M	4K
Pretax Income	-137.73M	-67.81M	-51.98M	-37.84M
Net Income	-137.95M	-68M	-51.99M	-37.85M
Selling & General & Admin	30.51M	18.77M	9.27M	6.34M
Research & Development	125.1M	63.62M	30.62M	31.31M
Other Expenses	n/a	n/a	n/a	n/a
Operating Expenses	155.6M	82.39M	39.89M	37.66M
Interest Expense	n/a	n/a	n/a	112K
Selling & Marketing Expenses	n/a	n/a	n/a	n/a
Cost & Expenses	155.6M	82.39M	39.89M	37.66M
Income Tax Expense	217K	187K	5K	1K
Shares Outstanding (Basic)	54.68M	54.42M	51.76M	51.76M
Shares Outstanding (Diluted)	54.68M	54.42M	51.76M	51.76M
EPS (Basic)	-2.52	-1.25	-1	-0.73
EPS (Diluted)	-2.52	-1.25	-1	-0.73
EBITDA	-137.63M	-67.75M	-51.96M	-37.72M
EBIT	-137.73M	-67.81M	-51.98M	-37.73M
Depreciation & Amortization	105K	56K	19K	10K